Drug Transporter (DT) Information

General Information of DT
DT ID DTD0132
Gene Name SLC1A4
Protein Name Alanine/serine/cysteine/threonine transporter 1
Gene ID
6509
UniProt ID
P43007
TCDB ID
2.A.23.3.1
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 6RVX_A

Identity: 62.42%

Minimized Score: -1140.506 kcal/mol

Detail: Structure Info

Synonyms ASCT-1; ASCT1; Neutral amino acid transporter A; SATT; SLC1A4; SPATCCM; Solute carrier family 1 member 4
DT Family Dicarboxylate/Amino Acid:Cation (Na(+) Or H(+)) Symporter (DAACS) Family ;
Tissue Specificity Expressed mostly in brain, muscle, andpancreas but detected in all tissues examined.
Function This tranporter exhibits sodium dependence and mediates the transport of alanine, serine, cysteine, and threonine.
Endogenous Substrate(s) Cysteine; Na+; Serine
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
L-alanine
 Approved Drug Info Glioma 2A00.0 [1]

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
D-serine
 Phase 4 Drug Info Serine deficiency disorder 5C50.6 [1]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
L-alanine Approved Drug Info Rat hippocampal astrocyte-ASCT1 Km = 194 microM [1]

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
D-serine Phase 4 Drug Info Oocytes-ASCT1 Km = 206 microM [1]
D-serine Phase 4 Drug Info Rat hippocampal astrocyte-ASCT1 Km = 2200 microM [1]
References
1 D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures. PLoS One. 2016 Jun 7;11(6):e0156551.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.